Clinical Trials
3 trialsNCT03863145 2024-02-07
Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors
Cosmo Pharmaceuticals NV
Phase EARLY_PHASE1 Unknown
NCT04892498 2022-08-09
Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0)
Second Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT02300467 2015-08-14
NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors
National OncoVenture
Phase 1 Unknown